Neoplasms, Malignant

Oncology
3
Pipeline Programs
1
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Sanofi
SanofiPARIS, France
3 programs
2
1
cabazitaxelPhase 1/21 trial
OmbrabulinPhase 11 trial
ombrabulinPhase 11 trial
Active Trials
NCT01193595Completed39Est. Oct 2014
NCT01021150Completed12Est. May 2011
NCT01001221Terminated19Est. Oct 2011

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Sanoficabazitaxel
SanofiOmbrabulin
Sanofiombrabulin

Clinical Trials (3)

Total enrollment: 70 patients across 3 trials

Dose-Escalation, Safety, Pharmacokinetics Study of Cabazitaxel With Gemcitabine In Patients With Solid Tumor

Start: Nov 2009Est. completion: Oct 201119 patients
Phase 1/2Terminated

Dose-escalation, Safety, Pharmacokinetics Study of AVE8062 Combined With Bevacizumab in Patients With Advanced Solid Tumors

Start: Sep 2010Est. completion: Oct 201439 patients
Phase 1Completed

Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Cisplatin in Patients With Solid Tumors

Start: Mar 2010Est. completion: May 201112 patients
Phase 1Completed

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space